Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Cancer Biotherapy & Radiopharmaceuticals|July 10, 2014
Planning combined treatments of external beam radiation therapy and molecular radiotherapyMarta Cremonesi, Mahila Ferrari, Francesca Botta, et al.Future Oncology (London, England)|December 9, 2021
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?Francesca Magnoni, Giovanni Corso, Laura Gilardi, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2009
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningiomaMirco Bartolomei, Lisa Bodei, Concetta De Cicco, et al.Endocrine|June 5, 2025
Enhancing patient-centered care with AI: a study of responses to neuroendocrine neoplasms queriesFrancesco Panzuto, Alessandro Gallo, Marco Marini, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2007
High-dose radioimmunotherapy with 90Y-ibritumomab tiuxetan: comparative dosimetric study for tailored treatmentMarta Cremonesi, Mahila Ferrari, Chiara Maria Grana, et al.Theranostics|December 8, 2025
Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH studyGiulia Santo, Margarida Rodrigues, Diana Paez, et al.Diagnostics (Basel, Switzerland)|December 24, 2021
A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)Alice Laffi, Marzia Colandrea, Giuseppe Buonsanti, et al.Surgery|December 30, 2017
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasmsStefano Partelli, Emilio Bertani, Mirco Bartolomei, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2015
Long-term results of PRRT in advanced bronchopulmonary carcinoidAnnapaola Mariniello, Lisa Bodei, Carmine Tinelli, et al.Oncology|June 10, 2020
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?Giovanni Corso, Laura Gilardi, Antonia Girardi, et al.Pageof 5